Annual EBITDA
-$74.40 M
-$4.24 M-6.05%
31 December 2023
Summary:
Ikena Oncology annual earnings before interest, taxes, depreciation & amortization is currently -$74.40 million, with the most recent change of -$4.24 million (-6.05%) on 31 December 2023. During the last 3 years, it has fallen by -$30.18 million (-68.25%). IKNA annual EBITDA is now -307.68% below its all-time high of -$18.25 million, reached on 31 December 2019.IKNA EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$11.51 M
+$3.54 M+23.54%
30 September 2024
Summary:
Ikena Oncology quarterly earnings before interest, taxes, depreciation & amortization is currently -$11.51 million, with the most recent change of +$3.54 million (+23.54%) on 30 September 2024. Over the past year, it has increased by +$7.76 million (+40.27%). IKNA quarterly EBITDA is now -489.34% below its all-time high of $2.96 million, reached on 31 December 2021.IKNA Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$63.58 M
+$7.76 M+10.87%
30 September 2024
Summary:
Ikena Oncology TTM earnings before interest, taxes, depreciation & amortization is currently -$63.58 million, with the most recent change of +$7.76 million (+10.87%) on 30 September 2024. Over the past year, it has increased by +$4.12 million (+6.08%). IKNA TTM EBITDA is now -795.25% below its all-time high of -$7.10 million, reached on 31 March 2020.IKNA TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IKNA EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -6.0% | +40.3% | +6.1% |
| 3 y3 years | -68.3% | +20.0% | -1.7% |
| 5 y5 years | - | - | - |
IKNA EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -121.5% | at low | -489.3% | +46.7% | -89.3% | +14.7% |
| 5 y | 5 years | -307.7% | at low | -489.3% | +55.7% | -795.3% | +14.7% |
| alltime | all time | -307.7% | at low | -489.3% | +55.7% | -795.3% | +14.7% |
Ikena Oncology EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$11.51 M(-23.5%) | -$63.58 M(-10.9%) |
| June 2024 | - | -$15.05 M(-2.4%) | -$71.34 M(-4.3%) |
| Mar 2024 | - | -$15.43 M(-28.6%) | -$74.54 M(+0.2%) |
| Dec 2023 | -$74.40 M(+6.0%) | -$21.60 M(+12.2%) | -$74.40 M(+9.9%) |
| Sept 2023 | - | -$19.26 M(+5.6%) | -$67.70 M(+2.4%) |
| June 2023 | - | -$18.25 M(+19.4%) | -$66.10 M(-3.7%) |
| Mar 2023 | - | -$15.28 M(+2.5%) | -$68.65 M(-2.1%) |
| Dec 2022 | -$70.15 M | -$14.90 M(-15.6%) | -$70.15 M(+34.2%) |
| Sept 2022 | - | -$17.66 M(-15.1%) | -$52.29 M(+6.7%) |
| June 2022 | - | -$20.80 M(+24.0%) | -$49.01 M(+20.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$16.78 M(-667.9%) | -$40.74 M(+21.3%) |
| Dec 2021 | -$33.59 M(-24.0%) | $2.96 M(-120.6%) | -$33.59 M(-46.3%) |
| Sept 2021 | - | -$14.38 M(+14.6%) | -$62.53 M(+15.0%) |
| June 2021 | - | -$12.54 M(+30.2%) | -$54.38 M(+17.3%) |
| Mar 2021 | - | -$9.63 M(-62.9%) | -$46.36 M(+5.8%) |
| Dec 2020 | -$44.22 M(+142.3%) | -$25.98 M(+316.8%) | -$43.83 M(+145.5%) |
| Sept 2020 | - | -$6.23 M(+38.0%) | -$17.85 M(+53.6%) |
| June 2020 | - | -$4.52 M(-36.4%) | -$11.62 M(+63.6%) |
| Mar 2020 | - | -$7.10 M | -$7.10 M |
| Dec 2019 | -$18.25 M | - | - |
FAQ
- What is Ikena Oncology annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Ikena Oncology?
- What is Ikena Oncology annual EBITDA year-on-year change?
- What is Ikena Oncology quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Ikena Oncology?
- What is Ikena Oncology quarterly EBITDA year-on-year change?
- What is Ikena Oncology TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Ikena Oncology?
- What is Ikena Oncology TTM EBITDA year-on-year change?
What is Ikena Oncology annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of IKNA is -$74.40 M
What is the all time high annual EBITDA for Ikena Oncology?
Ikena Oncology all-time high annual earnings before interest, taxes, depreciation & amortization is -$18.25 M
What is Ikena Oncology annual EBITDA year-on-year change?
Over the past year, IKNA annual earnings before interest, taxes, depreciation & amortization has changed by -$4.24 M (-6.05%)
What is Ikena Oncology quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of IKNA is -$11.51 M
What is the all time high quarterly EBITDA for Ikena Oncology?
Ikena Oncology all-time high quarterly earnings before interest, taxes, depreciation & amortization is $2.96 M
What is Ikena Oncology quarterly EBITDA year-on-year change?
Over the past year, IKNA quarterly earnings before interest, taxes, depreciation & amortization has changed by +$7.76 M (+40.27%)
What is Ikena Oncology TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of IKNA is -$63.58 M
What is the all time high TTM EBITDA for Ikena Oncology?
Ikena Oncology all-time high TTM earnings before interest, taxes, depreciation & amortization is -$7.10 M
What is Ikena Oncology TTM EBITDA year-on-year change?
Over the past year, IKNA TTM earnings before interest, taxes, depreciation & amortization has changed by +$4.12 M (+6.08%)